Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US9839631 | HATCHTECH | Methods and compositions for controlling ectoparasites |
Jul, 2024
(2 months from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8212038 | HATCHTECH | Methods and compositions for controlling ectoparasites |
Jul, 2024
(2 months from now) | |
US9357783 | HATCHTECH | Methods and compositions for controlling ectoparasites |
Jul, 2024
(2 months from now) | |
US7812163 | HATCHTECH | Methods and compositions for controlling ectoparasites |
Oct, 2026
(2 years from now) | |
US10292389 | HATCHTECH | Pediculicidal composition |
Dec, 2034
(10 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Chemical Entity Exclusivity(NCE) | Jul 24, 2025 |
NCE-1 date: 24 July, 2024
Market Authorisation Date: 24 July, 2020
Treatment: Topical treatment of head lice infestation in patients 6 months of age and older
Dosage: LOTION;TOPICAL